✦ LIBER ✦

437 Dendritic cell-based allogeneic immunotherapy of metastatic renal cell carcinoma: Immune and clinical responses only in combination with cyclophosphamide

✍ Scribed by M. Thurnher; L. Höltl; R. Ramoner; C. Zelle Rieser; H. Gander; C. Papesh; W. Nussbaumer; G. Bartsch

Book ID: 118645647
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 175 KB
Volume: 3
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(04)90434-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1799 GENE EXPRESSION PROFILES OF LYMPHOC

1799 GENE EXPRESSION PROFILES OF LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY

✍ Schwaab, Thomas; Wolf, Benita; Schwarzer, Adrian; Hampton, Thomas; Fisher, Jan; 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Allogeneic Dendritic Cells Fused with Tu

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

✍ Marten, Angela; Renoth, Sabine; Heinicke, Thomas; Albers, Peter; Pauli, Andreas; 📂 Article 📅 2003 🏛 Mary Ann Liebert 🌐 English ⚖ 506 KB

1796 PREDICTION FOR AND MECHANISM OF RES

1796 PREDICTION FOR AND MECHANISM OF RESPONSE TO DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY IN METASTATIC RENAL CELL CARCINOMA (RCC)– GENE EXPRESSION PROFILING OF PERIPHERAL BLOOD LYMPHOCYTES (PBL)

✍ Schwaab, Thomas; Hampton, Thomas; Wolf, Benita; Schwarzer, Adrian; Gui, Jiang; F 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 71 KB

Granulocyte-macrophage–colony stimulatin

Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f

Immunotherapy with interleukin-2 (IL2) a

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

✍ Escudier, B; Farace, F; Angevin, E; Charpentier, F; Nitenberg, G; Triebel, F; He 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 780 KB

MP35-06 EFFECTS OF DENDRITIC CELL-BASED

MP35-06 EFFECTS OF DENDRITIC CELL-BASED AD-GM∙CAIX VACCINE AS MONOTHERAPY OR IN COMBINATION WITH SUNITINIB IN AN IMMUNOCOMPETENT MOUSE MODEL OF METASTATIC RENAL CELL CARCINOMA

✍ Rampersaud, Edward N.; Said, Jonathan W.; Bot, Adrian; Birkhäuser, Frédéric D.; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 45 KB